Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline + Piperacillin/Tazobactam for Sepsis in Abdominal Infection
NCT02191475Phase 3Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- May 2014
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tigecycline in Intra-abdominal infection (IAI), sepsis, septic shock, sponsored by Tianjin Medical University Cancer Institute and Hospital. Status: unknown.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)sepsisseptic shock
Beyond the preview
Go deeper on NCT02191475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191475.